Avexegen Therapeutics is developing therapies based on Neuregulin-4 (NRG-4), a naturally occurring peptide found in human breast milk, for gastrointestinal disorders including inflammatory bowel disease
Avexegen Therapeutics is developing therapies based on Neuregulin-4 (NRG-4), a naturally occurring peptide found in human breast milk, for gastrointestinal disorders including inflammatory bowel disease.